Get the Stockscreener App
17.09
3.01%
-0.53
After Hours:
17.03
-0.06
-0.35%
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $17.09, with a volume of 6.16M.
It is down -3.01% in the last 24 hours and down -21.86% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
See More
Previous Close:
$17.62
Open:
$17.5
24h Volume:
6.16M
Relative Volume:
0.64
Market Cap:
$8.79B
Revenue:
$11.24B
Net Income/Loss:
$-900.00M
P/E Ratio:
-10.18
EPS:
-1.679
Net Cash Flow:
$323.00M
1W Performance:
-5.32%
1M Performance:
-21.86%
6M Performance:
-27.86%
1Y Performance:
-50.48%
1-Day Range:
$17.09
$17.50
1-Week Range:
$16.84
$18.55
52-Week Range:
$16.84
$34.55
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(224) 948-2000
Address
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.09 | 8.79B | 11.24B | -900.00M | 323.00M | -1.679 |
|
ISRG
Intuitive Surgical Inc
|
477.73 | 171.69B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.08 | 45.59B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.74 | 37.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.26 | 33.89B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.88 | 33.59B | 5.40B | 1.49B | 1.78B | 10.12 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Argus | Buy → Hold |
| Aug-04-25 | Downgrade | Stifel | Buy → Hold |
| Aug-01-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-26-25 | Resumed | Goldman | Buy |
| Feb-24-25 | Upgrade | Argus | Hold → Buy |
| Feb-20-25 | Resumed | Barclays | Overweight |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Baxter CFO Exit Tests Execution On Governance Reviews And Cost Discipline - simplywall.st
How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks? - Yahoo Finance
Baxter International: Anita Zielinski Named As Interim CFO - Pulse 2.0
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
BofA Securities Maintains Baxter International Inc(BAX.US) With Hold Rating, Announces Target Price $24 - 富途牛牛
Baxter Appoints Anita Zielinski As Interim CFO - citybiz
The ’Battleship’ Plan for 8.2%+ Dividends - Investing.com
Baxter (BAX) Reaffirms Modest Revenue Growth Outlook for FY26 - GuruFocus
Baxter (BAX) CFO Transition as Joel Grade Steps Down - GuruFocus
Baxter International (BAX) Announces CFO Transition - GuruFocus
BofA Maintains Neutral on Baxter International Inc. (BAX) March 2026 - Meyka
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Sets New 12-Month LowHere's What Happened - MarketBeat
Baxter Announces CFO Transition: Joel Grade Departs, Anita Zielinski Named Interim CFO, Reaffirms 2026 Outlook - Minichart
Baxter International stock hits 52-week low at $16.99 By Investing.com - Investing.com Canada
Baxter International stock hits 52-week low at $16.99 - Investing.com
Baxter says CFO Joel Grade is leaving the company - Crain's Chicago Business
Baxter International CFO Joel Grade to depart for family reasons - Medical Economics
BofA reiterates Baxter stock rating at Neutral on CFO transition - Investing.com
Baxter International (BAX) Announces CFO Transition and Interim Appointment - GuruFocus
Baxter International Inc. Announces the Departure of Joel Grade as Executive Vice President, Effective from April 30, 2026 - marketscreener.com
Baxter International Appoints Interim CFO Amid Leadership Transition - TipRanks
Baxter CFO Joel Grade to leave, Zielinski named interim - Investing.com
Baxter Announces CFO Transition - The Joplin Globe
How Investors Are Reacting To Baxter International (BAX) Governance Probes And Novum LVP Safety Allegations - simplywall.st
Assessing Baxter International (BAX) Valuation After Downgrades And Novum LVP Legal Scrutiny - Yahoo Finance
The Bull Case For Baxter International (BAX) Could Change Following New Governance And Safety Probes – Learn Why - Yahoo Finance
Is Baxter International (BAX) Now Attractive After Steep Multi Year Share Price Declines? - simplywall.st
Barclays Reaffirms Their Buy Rating on Baxter International (BAX) - The Globe and Mail
Dodge & Cox Has $1.31 Billion Position in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. (NYSE:BAX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Baxter International Inc. (NYSE: BAX) Long Term Investor Alert: Investigation of potential Wrongdoing - openPR.com
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter’s new CEO paid $29.8 million in first five months on the job - Crain's Chicago Business
Despite Near-Term Headwinds, Baxter Aims for a Turnaround Under New Management - Morningstar
Form PRE 14A BAXTER INTERNATIONAL For: May 05 - StreetInsider
Quantitative Investment Management LLC Makes New $2 Million Investment in Baxter International Inc. $BAX - MarketBeat
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Citi Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $19 - 富途牛牛
Why Baxter International Inc. stock remains undervaluedJuly 2025 Reactions & Community Driven Trade Alerts - mfd.ru
Citigroup Lowers Price Target for Baxter International (BAX) Ami - GuruFocus
Baxter at Barclays Conference: Strategic Shifts Amid Challenges - Investing.com
Baxter International (NYSE:BAX) Given New $19.00 Price Target at Citigroup - MarketBeat
Russell Investments Group Ltd. Has $57.24 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter (NYSE: BAX) SVP forfeits shares to cover tax withholding - Stock Titan
Baxter International Sees Unusually High Options Volume (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Sets New 52-Week LowWhat's Next? - MarketBeat
Baxter International stock hits 52-week low at $17.26 - Investing.com India
Blood Tubing Set Market Is Going to Boom Rapidly | Baxter International • Terumo Corporation • Fresenius Kabi - openPR.com
Baxter International Inc. $BAX Stake Increased by Gamco Investors INC. ET AL - MarketBeat
Gabelli Funds LLC Has $15.87 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):